Related Experiment Video
Updated: Jan 15, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Non-fistulous Bladder Ulceration in Crohn's Disease: A Rare Extraintestinal Manifestation
Alaa Jazzar1, Sani Beydoun1, Mahmoud Hallal2
1Urology, Lebanese University, Beirut, LBN.
Abstract:
Non-fistulous bladder ulceration is an extremely unusual extraintestinal manifestation of Crohn's disease (CD) with significant diagnostic and therapeutic challenges. We present a case of a 21-year-old male with ileocolonic CD, post-resection, who was admitted with repeated gross hematuria. Initial imaging (CT/MRI) revealed bladder wall thickening and an enterocolonic fistula, but no enterovesical communication. Cystoscopy revealed widespread mucosal erythema and ulceration, and histopathology was in keeping with chronic inflammation but not malignancy or granulomas. Multidisciplinary evaluation excluded malignancies and infections and led to a diagnosis of non-fistulous bladder ulceration associated with CD. Escalation of infliximab led to the resolution of hematuria and sustained remission at six-month follow-up. This case highlights the importance of recognition of atypical bladder involvement in CD patients with urinary symptoms, even in the absence of fistulas. Advanced imaging techniques, cystoscopy, and multidisciplinary cooperation are crucial for accurate diagnosis. Anti-tumor necrosis factor (TNF) therapy, particularly dose-intensified regimens, can effectively manage both intestinal and extraintestinal inflammation, suggesting the participation of shared immunopathogenic mechanisms. This review emphasizes the need for heightened clinical suspicion and multidisciplinary management to optimize outcomes in atypical CD-related complications.
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

